Sarcopenia in daily practice: assessment and management

Sarcopenia in daily practice: assessment and management

<p>BACKGROUND: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance i...

Detaylı Bibliyografya
Asıl Yazarlar:	Beaudart, C, McCloskey, E, Bruyère, O, Cesari, M, Rolland, Y, Rizzoli, R, Araujo de Carvalho, I, Amuthavalli Thiyagarajan, J, Bautmans, I, Bertière, M, Brandi, M, Al-Daghri, N, Burlet, N, Cavalier, E, Cerreta, F, Cherubini, A, Fielding, R, Gielen, E, Landi, F, Petermans, J, Reginster, J, Visser, M, Kanis, J, Cooper, C
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	BioMed Central 2016

Benzer Materyaller

Comparison of the performance of five screening methods for sarcopenia
Yazar:: Locquet M, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Pitfalls in the measurement of muscle mass: a need for a reference standard
Yazar:: Fanny Buckinx, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

Quality of life in sarcopenia and frailty.
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The Authors reply: “Dual energy X‐ray absorptiometry: gold standard for muscle mass?” by Scafoglieri et al.
Yazar:: Fanny Buckinx, ve diğerleri
Baskı/Yayın Bilgisi: (2018-08-01)

The authors reply: Letter on: “Pitfalls in the measurement of muscle mass: a need for a reference standard” by Clark et al.
Yazar:: Fanny Buckinx, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)

Management of osteoporosis of the oldest old (vol 25, pg 2507, 2014)
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
Yazar:: Bruyère, O, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Treatment of osteoporosis in men.
Yazar:: Kaufman, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study
Yazar:: Dolores Sanchez‐Rodriguez, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Challenges for the development of bone-forming agents in Europe
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Challenges for the development of bone-forming agents in Europe.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Yazar:: Bruyère, O, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
Yazar:: Rizzoli René, ve diğerleri
Baskı/Yayın Bilgisi: (2008-12-01)

Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
Yazar:: J Kanis, ve diğerleri
Baskı/Yayın Bilgisi: (2007-03-01)

Sarcopenia and health‐related quality of life: A systematic review and meta‐analysis
Yazar:: Charlotte Beaudart, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia
Yazar:: Beaudart, C, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art
Yazar:: Fuggle, NR, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Partial adherence: a new perspective on health economic assessment in osteoporosis.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL® questionnaire
Yazar:: Anton Geerinck, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Worldwide uptake of FRAX.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Changes in structure and symptoms in knee osteoarthritis and prediction of future knee replacement over 8 years.
Yazar:: Bruyere, O, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

CHANGES IN THE STRUCTURE AND THE SYMPTOMS OF THE OSTEOARTHRITIC KNEE AND PREDICTION OF FUTURE KNEE REPLACEMENT OVER AN 8-YEAR FOLLOW-UP PERIOD
Yazar:: Bruyere, O, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Predictive value of sarcopenia components for all-cause mortality: findings from population-based cohorts
Yazar:: Westbury, LD, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Development and validation of a disease model for postmenopausal osteoporosis.
Yazar:: Gauthier, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

DEVELOPMENT AND VALIDATION OF AN EPIDEMIOLOGICAL MODEL TO ESTIMATE THE BURDEN OF POST-MENOPAUSAL OSTEOPOROSIS
Yazar:: Gauthier, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Assessment of cardiovascular safety of anti-osteoporosis drugs
Yazar:: Fuggle, NR, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

KAL'TsIY I VITAMIN D V VEDENIIOSTEOPOROZA
Yazar:: R RIZZOLI, ve diğerleri
Baskı/Yayın Bilgisi: (2007-08-01)

A reappraisal of generic bisphosphonates in osteoporosis.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
Yazar:: Cooper, C, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Tools in the assessment of sarcopenia.
Yazar:: Cooper, C, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Variations in latitude may or may not explain the worldwide variation in hip fracture incidence
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)